US FDA’s New Drug Median Review Time Held Steady At Eight Months In 2021

 
• By Bridget Silverman

The median review time for novel agents at CDER hasn’t changed in five years. Our infographic offers a look at the tortoises and hares (all of them winners because they got approved).

FDA review times are track.
FDA continues to speed through novel drug reviews. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers